Search

Search Results

• P103 | ALEXITHYMIA INCREASES THE RISK OF MIGRAINE CHRONIFICATION IN WOMEN WITHOUT DEPRESSION

  E. Rota¹, E. Rubino², V. Batti², M. Trucco¹, S. Bottiroli^3|4, M. Cangelosi^3|4, A. Doretti⁵, F. Govone⁶, D. Ferrandi⁷, C. Lanni⁷, C. Cavestro⁸, M. Demaestri⁸, E. Canale⁹, V. Sciruicchio¹⁰, A. Di Gioia¹⁰, A. Passarini¹¹, I. Toldo¹², S. Di Antonio¹, A. Versace¹³, E. Cavagnetto¹, L. Savi², A. Battaggia¹⁴ | ¹Neurology Unit, San Giacomo Hospital, Novi Ligure, ASL AL, Italy; ²Department of Neuroscience “Rita Levi Montalcini”, University of Turin, Italy; ³Department of Brain and Behavioral Sciences, University of Pavia, Italy; ⁴IRCCS Mondino Foundation, Pavia, Italy; ⁵Department of Neurology and Laboratory of Neuroscience, IRCCS Istituto Auxologico Italiano, Milano, Italy; ⁶Neurology Unit, Regina Montis Regalis Hospital, Mondovì, ASL CN1, Italy; ⁷Neurology Unit, San Biagio e Arrigo Hospital, Alessandria, AOU AL, Italy; ⁸Headache Center, Alba, ASL CN2, Italy; ⁹Child Neuropsychiatry Unit, IRCCS Istituto G. Gaslini, Genoa, Italy; ¹⁰Children Epilepsy and EEG Center, Bari, Italy; ¹¹Child Neuropsychiatry Unit, ASST Grande Ospedale Metropolitano Niguarda, Milano, Italy; ¹²Unit of Child Neurology and Neurophysiology, Women’s and Children’s Health Department University of Padova, Italy; ¹³Pediatric Headache Centre, Department of Pediatric Emergency, Regina Margherita Children’s Hospital, Turin, Italy; ¹⁴SVEMG – Scuola Veneta di Medicina Generale, Padova, Italy

  03-11-2026

  DOI https://doi.org/10.4081/cc.2026.16059

  • 0 abstract views
  • 0 PDF

• P032 | IMPROVEMENT IN DEPRESSIVE AND ANXIETY SYMPTOMS DURING EPTINEZUMAB TREATMENT: A POST-HOC ANALYSIS FROM THE TACHIS STUDY

  E.M. Piella¹, A.M. Chiarandon¹, V. Batti¹, D.A. Montisano², L. F. Iannone³, C. Fasano⁴, G. Sebastianelli⁵, G. Coppola⁵, D. Ferrandi⁶, C. Lanni⁷, M.P. Prudenzano⁸, M. De Tommaso⁹, P. Merlo¹⁰, A. Viganò¹⁰, F. De Cesaris¹¹, A. Chiarugi¹¹, A. Munafò¹¹, F. Pistoia¹², R. Ornello¹², S. Sacco¹², A. Doretti¹³, L. Grazzi², F. Lo Castro¹⁴, R. Allamprese¹⁴, R. De Icco^15|16, G. Vaghi^15|16, C. Tassorelli^15|16, G. Avino¹⁷, M. Romozzi¹⁸, C. Vollono¹⁸, P. Calabresi¹⁸, S. Battistini¹⁹, A. Rufa¹⁹, M. Albanese²⁰, M. Trimboli²¹, G. Carlucci⁴, M. Silvestro²², A. Russo²², M. Valente²³, L. Fofi²⁴, M. Marcosano²⁴, P. Geppetti²⁵, C. Altamura²⁴, F. Vernieri²⁴, E. Rubino¹, I. Rainero¹, S. Guerzoni¹⁴ | ¹Department of Neuroscience “Rita Levi Montalcini”, University of Turin, Italy; ²Headache Center, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milano, Italy; ³Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Italy; ⁴NEUROFARBA Department, University of Florence - Neurologia, AOU Careggi, Italy; ⁵Sapienza University of Rome, Department of Medico-Surgical Sciences and Biotechnologies, Polo Pontino, Latina, Italy; ⁶AOU Alessandria, SC Neurologia, Italy; ⁷Psicologia AOU Alessandria, Italy; ⁸Clinica Neurologica "L. Amaducci", Azienda Ospedaliero-Universitaria Consorziale di Bari, Italy; ⁹Neurophysiopathology Unit, Department of Translational Biomedicine and Neuroscience, University of Bari Aldo Moro, Italy; ¹⁰UO di Neurologia, Humanitas Gavazzeni, Bergamo, Italy; ¹¹Headache center and Clinical pharmacology unit, AOU Careggi, Florence, Italy; ¹²Department of Biotechnological and Applied Clinical Sciences, University of L'Aquila, Italy; ¹³Department of Neurology and Laboratory of Neuroscience, IRCCS Istituto Auxologico Italiano, Milano, Italy; ¹⁴Digital and Predictive Medicine, Pharmacology, Clinical Metabolic Toxicology-Headache Center and Drug Abuse, Laboratory of Clinical Pharmacology and Pharmacogenomics, AOU Policlinico, Modena, Italy; ¹⁵Department of Brain and Behavioral Sciences, University of Pavia, Italy; ¹⁶Headache Science and Neurorehabilitation Unit, IRCCS Mondino Foundation, Pavia, Italy; ¹⁷SOC Neurologia, Ospedale di Prato, Italy; ¹⁸Fondazione Policlinico Universitario A. Gemelli IRCCS, Università Cattolica del Sacro Cuore, Roma, Italy; ¹⁹Department of Medical, Surgical and Neurological Sciences, University of Siena, Italy; ²⁰Unit of Neurology, Department of Systems Medicine, University of Rome Tor Vergata, Italy; ²¹Headache Center, Unit of Neurology, AOU Renato Dulbecco, Catanzaro, Italy; ²²Inter-departmental Program of Headache Medicine and Primary Pain Syndromes, Department of Advanced Medical and Surgical Sciences, University of Campania “Luigi Vanvitelli”, Naples, Italy; ²³DMED, University of Udine and Clinical Neurology, Udine University Hospital, Italy; ²⁴Fondazione Policlinico Universitario Campus Bio-Medico, Roma e Università Campus Bio-Medico di Roma, Italy; ²⁵Department of Molecular Pathobiology and Pain Research Center, College of Dentistry, New York University, NY, USA

  03-11-2026

  DOI https://doi.org/10.4081/cc.2026.15988

  • 0 abstract views
  • 0 PDF

• P089 | PRELIMINARY VALIDATION OF THE ITALIAN VERSION OF THE UTAH PHOTOPHOBIA SYMPTOM IMPACT SCALE (UPSIS-2) IN PATIENTS WITH MIGRAINE

  A.M. Chiarandon¹, E.M. Piella¹, V. Batti¹, G. Sebastianelli², F. Ferrandes¹, M. Corrado³, M. Romozzi⁴, F. De Santis⁵, C. Fasano⁶, F. Lazzerini⁷, L. F. Iannone⁸, A. Munafò⁹, R. Ornello¹⁰, E. Rubino^1|11, I. Rainero^1|11 | ¹Department of Neuroscience “Rita Levi Montalcini”, University of Turin, Italy; ²Department of Medico-Surgical Sciences and Biotechnologies, Sapienza University of Rome, Polo Pontino, Latina, Italy; ³Department of Brain and Behavioral Sciences, University of Pavia, Italy; ⁴Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome; Università Cattolica del Sacro Cuore, Rome, Italy; ⁵Department of Biotechnological and Applied Clinical Sciences, University of L’Aquila, Italy; ⁶Headache and Cerebrovascular Diseases Center, Neurology Unit 2, Careggi University Hospital, Florence, Italy; ⁷Department of Humanities, University of Turin, Italy; ⁸Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Italy; ⁹Headache center and Clinical pharmacology unit, AOU Careggi, Florence, Italy; ¹⁰Department of Biotechnological and Applied Clinical Sciences, University of L'Aquila, Italy; ¹¹Headache Center, Department of Neuroscience and Mental Health, City of Health and Science of Turin, Italy, on behalf of SISC Junior Group

  03-11-2026

  DOI https://doi.org/10.4081/cc.2026.16045

  • 0 abstract views
  • 0 PDF

• P082 | CHARACTERIZING SOCIAL COGNITION ACROSS MIGRAINE FREQUENCY USING THE STORY-BASED EMPATHY TASK AND THE READING THE MIND IN THE EYES TEST

  V. Batti¹, A. Mario Chiarandon¹, E. Maria Piella¹, A. Agostinelli¹, E. Rota³, I. Rainero^1|2, E. Rubino^1|2 | ¹Department of Neuroscience “Rita Levi Montalcini”, University of Turin, Italy; ²Headache Center, Department of Neuroscience and Mental Health, University Hospital Città della Salute e della Scienza of Turin, Italy; ³Neurology Unit, S. Giacomo Hospital, ASL AL, Novi Ligure, Italy

  03-11-2026

  DOI https://doi.org/10.4081/cc.2026.16038

  • 0 abstract views
  • 0 PDF

• OC03 | PLASMA PACAP-38 IS INCREASED IN MIGRAINE REGARDLESS OF CLINICAL PHENOTYPE: A CASE-CONTROL STUDY

  S. Boschi^1|2, A. Agostinelli^1|2, A. Panza^1|2, E. Maria Piella^1|2, V. Batti^1|2, I. Rainero^1|2, E. Rubino^1|2 | ¹Dipartimento di Neuroscienze "Rita Levi Montalcini", Università di Torino, Italy; ²Centro Cefalee, Dipartimento di Neuroscienze e Salute Mentale, AOU Città della Salute e della Scienza di Torino, Italy

  03-11-2026

  DOI https://doi.org/10.4081/cc.2026.15941

  • 0 abstract views
  • 0 PDF